{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:59:33Z","timestamp":1767211173160,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00392-021-01891-2","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T20:02:56Z","timestamp":1623700976000},"page":"50-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial"],"prefix":"10.1007","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"John G.","family":"Cleland","sequence":"additional","affiliation":[]},{"given":"Carolyn S. P.","family":"Lam","sequence":"additional","affiliation":[]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[]},{"given":"Mandeep R.","family":"Mehra","sequence":"additional","affiliation":[]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[]},{"given":"William M.","family":"Byra","sequence":"additional","affiliation":[]},{"given":"David A.","family":"LaPolice","sequence":"additional","affiliation":[]},{"given":"Barry","family":"Greenberg","sequence":"additional","affiliation":[]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"crossref","unstructured":"Ferreira JP, Girerd N, Alshalash S, Konstam MA, Zannad F (2016) Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges. Eur Heart J.","DOI":"10.1093\/eurheartj\/ehw213"},{"issue":"5","key":"1891_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, B\u00e4nsch D (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417\u2013427","journal-title":"N Engl J Med"},{"issue":"2","key":"1891_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jacep.2018.10.006","volume":"5","author":"M D\u00f6rr","year":"2019","unstructured":"D\u00f6rr M, Nohturfft V, Brasier N, Bosshard E, Djurdjevic A, Gross S, Raichle CJ, Rhinisperger M, St\u00f6ckli R, Eckstein J (2019) The Watch AF trial: SmartWATCHes for detection of atrial fibrillation. JACC Clin Electrophysiol 5(2):199\u2013208","journal-title":"JACC Clin Electrophysiol"},{"issue":"20","key":"1891_CR4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","volume":"381","author":"MV Perez","year":"2019","unstructured":"Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, Balasubramanian V, Russo AM, Rajmane A, Cheung L, Hung G, Lee J, Kowey P, Talati N, Nag D, Gummidipundi SE, Beatty A, Hills MT, Desai S, Granger CB, Desai M, Turakhia MP (2019) Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 381(20):1909\u20131917","journal-title":"N Engl J Med"},{"issue":"10201","key":"1891_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0140-6736(19)31721-0","volume":"394","author":"ZI Attia","year":"2019","unstructured":"Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ, Carter RE, Yao X, Rabinstein AA, Erickson BJ, Kapa S, Friedman PA (2019) An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet 394(10201):861\u2013867","journal-title":"Lancet"},{"issue":"7","key":"1891_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ejhf.266","volume":"17","author":"F Zannad","year":"2015","unstructured":"Zannad F, Greenberg B, Cleland JG, Gheorghiade M, van Veldhuisen DJ, Mehra MR, Anker SD, Byra WM, Fu M, Mills RM (2015) Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial. Eur J Heart Fail 17(7):735\u2013742","journal-title":"Eur J Heart Fail"},{"key":"1891_CR7","doi-asserted-by":"crossref","unstructured":"Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B (2018) Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. N Engl J Med.","DOI":"10.1056\/NEJMoa1808848"},{"issue":"44","key":"1891_CR8","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/eurheartj\/ehz427","volume":"40","author":"MR Mehra","year":"2019","unstructured":"Mehra MR, Vaduganathan M, Fu M, Ferreira JP, Anker SD, Cleland JGF, Lam CSP, van Veldhuisen DJ, Byra WM, Spiro TE, Deng H, Zannad F, Greenberg B (2019) A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J 40(44):3593\u20133602","journal-title":"Eur Heart J"},{"issue":"6","key":"1891_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/jamacardio.2019.1049","volume":"4","author":"B Greenberg","year":"2019","unstructured":"Greenberg B, Neaton JD, Anker SD, Byra WM, Cleland JGF, Deng H, Fu M, La Police DA, Lam CSP, Mehra MR, Nessel CC, Spiro TE, van Veldhuisen DJ, Vanden Boom CM, Zannad F (2019) Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial. JAMA Cardiol 4(6):515\u2013523","journal-title":"JAMA Cardiol"},{"key":"1891_CR10","doi-asserted-by":"crossref","unstructured":"Cunningham JW, Ferreira JP, Deng H, Anker SD, Byra WM, Cleland JGF, Gheorghiade M, Lam CSP, La Police D, Mehra MR, Neaton JD, Spiro TE, van Veldhuisen DJ, Greenberg B, Zannad F (2020) Natriuretic peptide-based inclusion criteria in a heart failure clinical trial: insights from COMMANDER HF. JACC Heart Fail.","DOI":"10.1016\/j.jchf.2019.12.009"},{"key":"1891_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"F Jp","year":"1999","unstructured":"Jp F, Rj G (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509","journal-title":"J Am Stat Assoc"},{"issue":"36","key":"1891_CR12","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1093\/eurheartj\/eht247","volume":"34","author":"TJ Collier","year":"2013","unstructured":"Collier TJ, Pocock SJ, McMurray JJ, Zannad F, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B (2013) The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial. Eur Heart J 34(36):2823\u20132829","journal-title":"Eur Heart J"},{"issue":"17","key":"1891_CR13","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/CIRCULATIONAHA.114.013760","volume":"131","author":"AH Abdul-Rahim","year":"2015","unstructured":"Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ (2015) Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Insufficienza cardiaca-heart failure (GISSI-HF) Trials. Circulation 131(17):1486\u20131494","journal-title":"Circulation"},{"issue":"3","key":"1891_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/cvr\/cvp066","volume":"82","author":"JI Borissoff","year":"2009","unstructured":"Borissoff JI, Spronk HM, Heeneman S, ten Cate H (2009) Is thrombin a key player in the \u2018coagulation-atherogenesis\u2019 maze? Cardiovasc Res 82(3):392\u2013403","journal-title":"Cardiovasc Res"},{"issue":"10","key":"1891_CR15","first-page":"742","volume":"38","author":"AH Abdul-Rahim","year":"2017","unstructured":"Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV (2017) Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-preserved and i-preserve trials. Eur Heart J 38(10):742\u2013750","journal-title":"Eur Heart J"},{"issue":"7","key":"1891_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jacc.2017.12.011","volume":"71","author":"JP Ferreira","year":"2018","unstructured":"Ferreira JP, Girerd N, Gregson J, Latar I, Sharma A, Pfeffer MA, McMurray JJV, Abdul-Rahim AH, Pitt B, Dickstein K, Rossignol P, Zannad F (2018) Stroke risk in patients with reduced ejection fraction after myocardial infarction without atrial fibrillation. J Am Coll Cardiol 71(7):727\u2013735","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1891_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","volume":"148","author":"JG Cleland","year":"2004","unstructured":"Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA (2004) The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 148(1):157\u2013164","journal-title":"Am Heart J"},{"issue":"4","key":"1891_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","volume":"8","author":"DV Cokkinos","year":"2006","unstructured":"Cokkinos DV, Haralabopoulos GC, Kostis JB, Toutouzas PK (2006) Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study. Eur J Heart Fail 8(4):428\u2013432","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1891_CR19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","volume":"119","author":"BM Massie","year":"2009","unstructured":"Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O\u2019Connor CM, Schulman KA, Teo K, Warren SR (2009) Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation 119(12):1616\u20131624","journal-title":"Circulation"},{"issue":"20","key":"1891_CR20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","volume":"366","author":"S Homma","year":"2012","unstructured":"Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R (2012) Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 366(20):1859\u20131869","journal-title":"N Engl J Med"},{"key":"1891_CR21","doi-asserted-by":"crossref","unstructured":"Ferreira JP, Lam CSP, Anker SD, Mehra MR, van Veldhuisen DJ, Byra WM, La Police DA, Cleland JGF, Greenberg B, Zannad F (2020) Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial. Eur J Heart Fail.","DOI":"10.1002\/ejhf.2003"},{"issue":"3","key":"1891_CR22","doi-asserted-by":"publisher","first-page":"e005393","DOI":"10.1161\/CIRCEP.117.005393","volume":"11","author":"MN Belkin","year":"2018","unstructured":"Belkin MN, Soria CE, Waldo AL, Borleffs CJW, Hayes DL, Tung R, Singh JP, Upadhyay GA (2018) Incidence and clinical significance of new-onset device-detected atrial tachyarrhythmia: a meta-analysis. Circ Arrhythm Electrophysiol 11(3):e005393","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"1891_CR23","doi-asserted-by":"publisher","first-page":"e000651","DOI":"10.1136\/openhrt-2017-000651","volume":"4","author":"S Degrauwe","year":"2017","unstructured":"Degrauwe S, Pilgrim T, Aminian A, Noble S, Meier P, Iglesias JF (2017) Dual antiplatelet therapy for secondary prevention of coronary artery disease. Open Heart 4(2):e000651","journal-title":"Open Heart"},{"issue":"23","key":"1891_CR24","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzar IE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM (2014) Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371(23):2155\u20132166","journal-title":"N Engl J Med"},{"issue":"4","key":"1891_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11897-004-0002-y","volume":"1","author":"GS Bhatia","year":"2004","unstructured":"Bhatia GS, Lip GY (2004) Atrial fibrillation post-myocardial infarction: frequency, consequences, and management. Curr Heart Fail Rep 1(4):149\u2013155","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"1891_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","volume":"136","author":"DH Lau","year":"2017","unstructured":"Lau DH, Nattel S, Kalman JM, Sanders P (2017) Modifiable risk factors and atrial fibrillation. Circulation 136(6):583\u2013596","journal-title":"Circulation"},{"issue":"2","key":"1891_CR27","doi-asserted-by":"publisher","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","volume":"2","author":"A Alonso","year":"2013","unstructured":"Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, K\u00e4\u00e4b S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ (2013) Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2(2):e000102","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1891_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ejhf.1131","volume":"20","author":"JP Ferreira","year":"2018","unstructured":"Ferreira JP, Duarte K, Pfeffer MA, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P (2018) Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and\/or heart failure: an analysis from the high-risk myocardial infarction database initiative. Eur J Heart Fail 20(2):323\u2013331","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"1891_CR29","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","volume":"30","author":"J Schmitt","year":"2009","unstructured":"Schmitt J, Duray G, Gersh BJ, Hohnloser SH (2009) Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 30(9):1038\u20131045","journal-title":"Eur Heart J"},{"issue":"4","key":"1891_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jce.12066","volume":"24","author":"CP Lau","year":"2013","unstructured":"Lau CP, Gbadebo TD, Connolly SJ, Van Gelder IC, Capucci A, Gold MR, Israel CW, Morillo CA, Siu CW, Abe H, Carlson M, Tse HF, Hohnloser SH, Healey JS (2013) Ethnic differences in atrial fibrillation identified using implanted cardiac devices. J Cardiovasc Electrophysiol 24(4):381\u2013387","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"1891_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ahj.2009.05.010","volume":"158","author":"A Alonso","year":"2009","unstructured":"Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR (2009) Incidence of atrial fibrillation in whites and African-Americans: the atherosclerosis risk in communities (ARIC) study. Am Heart J 158(1):111\u2013117","journal-title":"Am Heart J"},{"issue":"3","key":"1891_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jchf.2020.11.007","volume":"9","author":"JP Ferreira","year":"2021","unstructured":"Ferreira JP, Cleland JGF, Lam CSP, van Veldhuisen DJ, Byra WM, La Police DA, Anker SD, Mehra MR, Leroy C, Eschwege V, Toussaint-Hacquard M, Rossignol P, Greenberg B, Zannad F (2021) Impact of geographic region on the COMMANDER-HF trial. JACC Heart Fail 9(3):201\u2013211","journal-title":"JACC Heart Fail"},{"issue":"23","key":"1891_CR33","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.jacc.2016.09.940","volume":"68","author":"S Jamaly","year":"2016","unstructured":"Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sj\u00f6str\u00f6m L, Karason K (2016) Bariatric surgery and the risk of new-onset atrial fibrillation in swedish obese subjects. J Am Coll Cardiol 68(23):2497\u20132504","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1891_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00392-019-01453-7","volume":"108","author":"S Stienen","year":"2019","unstructured":"Stienen S, Ferreira JP, Girerd N, Duarte K, Lamiral Z, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P (2019) Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and\/or heart failure: insights from the high-risk myocardial Infarction Initiative. Clin Res Cardiol 108(11):1215\u20131225","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"1891_CR35","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ijo.2013.203","volume":"38","author":"R Padwal","year":"2014","unstructured":"Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A (2014) The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 38(8):1110\u20131114","journal-title":"Int J Obes (Lond)"},{"key":"1891_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ahj.2008.02.014","volume":"156","author":"A Oreopoulos","year":"2008","unstructured":"Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J USA 156:13\u201322","journal-title":"Am Heart J USA"},{"issue":"1","key":"1891_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","volume":"38","author":"HM Spronk","year":"2017","unstructured":"Spronk HM, De Jong AM, Verheule S, De Boer HC, Maass AH, Lau DH, Rienstra M, van Hunnik A, Kuiper M, Lumeij S, Zeemering S, Linz D, Kamphuisen PW, Ten Cate H, Crijns HJ, Van Gelder IC, van Zonneveld AJ, Schotten U (2017) Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Eur Heart J 38(1):38\u201350","journal-title":"Eur Heart J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01891-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T16:07:33Z","timestamp":1642522053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01891-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01891-2","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"type":"print","value":"1861-0684"},{"type":"electronic","value":"1861-0692"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest regarding the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}